Stay updated on Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A minor revision update was applied, changing the version from v3.4.1 to v3.4.2; no visible changes to study content or details are indicated. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T10:32:37.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1 in place of Revision: v3.4.0. This is a minor site update and does not affect the study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-02-04T10:16:32.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Minor UI/text updates include adding a 'Show glossary' option and a new version label 'Revision: v3.4.0', while updating/removing labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' versus their prior variants 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:45:25.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed on the page, replacing Revision: v3.3.3. This is a minor system update with no changes to study details.
    Difference
    0.1%
    Check dated 2026-01-14T02:17:39.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Footer updates include a new Revision: v3.3.3 notice, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries have been removed. These changes do not affect core study information, eligibility criteria, or enrollment data.
    Difference
    0.1%
    Check dated 2025-12-23T17:25:24.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The page revision marker was updated to v3.3.2 in the footer, and the previous revision entry v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T19:05:08.000Z thumbnail image

Stay in the know with updates to Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel-Pembrolizumab vs. Weekly Paclitaxel Clinical Trial page.